Read the Pre-eclampsia Supplement

Pre-eclampsia is one of the leading causes of maternal and perinatal morbidity and mortality. Globally, 76,000 women and 500,000 babies dies each year from the disorder. Women in low-resource countries are at a higher risk of developing hypertensive disorders of pregnancy and pre-eclampsia compared with those in high-resource countries.

This article is part of our new ongoing webinar summary series, aimed at providing information on all of the key points touched on at our webinars, available to disseminate widely. You can find the video recording to this webinar on the PONI initiative on our dedicated page.

This new supplement raises the importance of tackling malnutrition and obesity before, during and after pregnancy, to improve the long-term health of mothers and their children, and future generations.

In our 2019 Pre-eclampsia Guidelines FIGO called for countries to screen all women in the first trimester, integrating pre-eclampsia risk assessment as an integral part of basic first-trimester evaluation protocol. 

Professor Liona Poon, Member of the FIGO Pregnancy and NCDs Committee, shares her commitment to integrating Pre-eclampsia risk assessment in Hong Kong.

Failure to integrate maternal and child health services with NCD prevention is a missed opportunity with long-term implications for the growing global NCD pandemic, says FIGO, with new comment piece published in The Lancet December 8 issue.